Neumora Therapeutics (NMRA) Other Non-Current Assets (2022 - 2025)

Neumora Therapeutics' Other Non-Current Assets history runs 4 years deep, the most recent figure standing at $53000.0 for Q4 2025.

• On a quarterly basis, Other Non-Current Assets fell 95.63% year-over-year to $53000.0 in Q4 2025; TTM through Dec 2025 was $53000.0, a 95.63% decrease from a year earlier, with the FY2025 full-year figure at $53000.0, down 95.63% from the prior year.
• Other Non-Current Assets declined to $53000.0 in Q4 2025 per NMRA's latest filing, from $298000.0 in the prior quarter.
• Across five years, Other Non-Current Assets topped out at $1.3 million in Q4 2022 and bottomed at $53000.0 in Q4 2025.
• The 4-year median for Other Non-Current Assets is $1.2 million (2023), against an average of $1.1 million.
• Across the five-year window, Other Non-Current Assets changed 0.0% in 2024 and slumped 95.63% in 2025, its largest moves.
• Year by year, Other Non-Current Assets stood at $1.3 million in 2022, then retreated by 3.96% to $1.2 million in 2023, then changed by 0.0% to $1.2 million in 2024, then slumped by 95.63% to $53000.0 in 2025.
• Per Business Quant, the three latest NMRA Other Non-Current Assets figures stand at $53000.0 (Q4 2025), $298000.0 (Q2 2025), and $1.2 million (Q1 2025).